5JMO image
Entry Detail
PDB ID:
5JMO
Title:
X-ray structure of furin in complex with the inhibitory antibody Nb14
Biological Source:
PDB Version:
Deposition Date:
2016-04-29
Release Date:
2016-12-07
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.19
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 21 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Furin
Chain IDs:A, B
Chain Length:482
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:camelid VHH fragment
Chain IDs:C, D
Chain Length:117
Number of Molecules:2
Biological Source:Camelus dromedarius
Polymer Type:polypeptide(L)
Description:CMK-inhibitor
Chain IDs:E (auth: G), F (auth: H)
Chain Length:6
Number of Molecules:2
Biological Source:synthetic construct
Peptide-like Molecules
PRD_000278
Primary Citation
The structure of a furin-antibody complex explains non-competitive inhibition by steric exclusion of substrate conformers.
Sci Rep 6 34303 34303 (2016)
PMID: 27670069 DOI: 10.1038/srep34303

Abstact

Proprotein Convertases (PCs) represent highly selective serine proteases that activate their substrates upon proteolytic cleavage. Their inhibition is a promising strategy for the treatment of cancer and infectious diseases. Inhibitory camelid antibodies were developed, targeting the prototypical PC furin. Kinetic analyses of them revealed an enigmatic non-competitive mechanism, affecting the inhibition of large proprotein-like but not small peptidic substrates. Here we present the crystal structures of furin in complex with the antibody Nb14 and of free Nb14 at resolutions of 2.0 Å and 2.3 Å, respectively. Nb14 binds at a site distant to the substrate binding pocket to the P-domain of furin. Interestingly, no major conformational changes were observed upon complex formation, neither for the protease nor for the antibody. Inhibition of furin by Nb14 is instead explained by steric exclusion of specific substrate conformers, explaining why Nb14 inhibits the processing of bulky protein substrates but not of small peptide substrates. This mode of action was further supported by modelling studies with the ternary factor X-furin-antibody complex and a mutation that disrupted the interaction interface between furin and the antibody. The observed binding mode of Nb14 suggests a novel approach for the development of highly specific antibody-based proprotein convertase inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures